1. Nilsen ST, Pedersen AT, Moen MH, Milsom I, Mattsson LA, Iversen OE, Larsen PM, Andersson K. Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and Sweden. Maturitas 2001; 39:83-90.
2. Ladfors L, Eriksson M, Mattsson LA, Kyleback K, Magnusson L, Milsom I. A population based study of Swedish women's opinions about antenatal, delivery and postpartum care. Acta Obstet Gynecol Scand 2001; 80:130-6.
3. Stadberg E, Mattsson LA, Milsom I. Factors associated with climacteric symptoms and the use of hormone replacement therapy. Acta Obstet Gynecol Scand 2000; 79:286-92.
4. Mattsson LA, Christiansen C, Colau JC, Palacios S, Kenemans P, Bergeron C, Chevallier O, Von Holst T, Gangar K. Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms. Am J Obstet Gynecol 2000; 182:545-52.
5. Ladfors L, Mattsson LA, Eriksson M, Milsom I. Prevalence and risk factors for prelabor rupture of the membranes (PROM) at or near-term in an urban Swedish population. J Perinat Med 2000; 28:491-6.
6. Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 1999; 19:89-99.
7. Stadberg E, Westlund P, Landgren BM, Aedo AR, Cekan SZ, Mattsson LA. Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women. Maturitas 1999; 33:59-69.
8. Olsson R, Mattsson LA, Obrant K, Mellstrom D. Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 1999; 19:188-92.
9. Mattsson LA, Bohnet HG, Gredmark T, Torhorst J, Hornig F, Huls G. Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations. Obstet Gynecol 1999; 94:61-5.
10. Luzietti R, Erkkola R, Hasbargen U, Mattsson LA, Thoulon JM, Rosen KG. European Community multi-Center Trial "Fetal ECG Analysis During Labor": ST plus CTG analysis. J Perinat Med 1999; 27:431-40.
11. Lindgren R, Mattsson LA, Andersson K, Lagrelius A, Sandin K, Karlsson K, Risberg B. Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women on hormone replacement therapy. Br J Obstet Gynaecol 1999; 106:421-6.
12. Ladfors L, Mattsson LA. Is the use of IGFB-1 for diagnosing ROM of any clinical value. Acta Obstet Gynecol Scand 1999; 78:557-8.
13. Hahn L, Mattsson LA, Andersson B, Tengborn L. The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus. Blood Coagul Fibrinolysis 1999; 10:81-6.
14. Gredmark T, Kvint S, Havel G, Mattsson LA. Adipose tissue distribution in postmenopausal women with adenomatous hyperplasia of the endometrium. Gynecol Oncol 1999; 72:138-42.
15. Andersson B, Mattsson LA. The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM. Acta Obstet Gynecol Scand 1999; 78:260-1.
16. Ladfors L, Tessin I, Mattsson LA, Eriksson M, Seeberg S, Fall O. Risk factors for neonatal sepsis in offspring of women with prelabor rupture of the membranes at 34-42 weeks. J Perinat Med 1998; 26:94-101.
17. Andersson K, Pedersen AT, Mattsson LA, Milsom I. Swedish gynecologists' and general practitioners' views on the climacteric period: knowledge, attitudes and management strategies. Acta Obstet Gynecol Scand 1998; 77:909-16.
18. Wollter-Svensson LO, Stadberg E, Andersson K, Mattsson LA, Odlind V, Persson I. Intrauterine administration of levonorgestrel 5 and 10 microg/24 hours in perimenopausal hormone replacement therapy. A randomized clinical study during one year. Acta Obstet Gynecol Scand 1997; 76:449-54.
19. Stadberg E, Mattsson LA, Milsom I. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand 1997; 76:442-8.
20. Stadberg E, Mattsson LA, Milsom I. Womens attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study. Maturitas 1997; 27:109-16.
21. Ladfors L, Mattsson LA, Eriksson M, Fall O. Is a speculum examination sufficient for excluding the diagnosis of ruptured fetal membranes? Acta Obstet Gynecol Scand 1997; 76:739-42.
22. Eriksson M, Mattsson LA, Ladfors L. Early or late bath during the first stage of labour: a randomised study of 200 women. Midwifery 1997; 13:146-8.
23. Andersson B, Mattsson LA, Hahn L, Marin P, Lapidus L, Holm G, Bengtsson BA, Bjorntorp P. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82:638-43.
24. Stadberg E, Mattsson LA, Uvebrant M. 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. Maturitas 1996; 23:31-9.
25. Mattsson LA, Stadberg E, Milsom I. Management of hormone replacement therapy: the Swedish experience. Eur J Obstet Gynecol Reprod Biol 1996; 64:S3-5.
26. Mattsson LA, Milsom I, Stadberg E. What do women want? Br J Obstet Gynaecol 1996; 103:104-6; discussion 106-7.
27. Ladfors L, Mattsson LA, Eriksson M, Fall O. A randomised trial of two expectant managements of prelabour rupture of the membranes at 34 to 42 weeks. Br J Obstet Gynaecol 1996; 103:755-62.
28. Eriksson M, Ladfors L, Mattsson LA, Fall O. Warm tub bath during labor. A study of 1385 women with prelabor rupture of the membranes after 34 weeks of gestation. Acta Obstet Gynecol Scand 1996; 75:642-4.
29. Andersson K, Stadberg E, Mattsson LA, Rybo G, Samsioe G. Intrauterine or oral administration of levonorgestrel in combination with estradiol to perimenopausal women--effects on lipid metabolism during 12 months of treatment. Int J Fertil Menopausal Stud 1996; 41:476-83.
30. Andersson K, Mattsson LA, Milsom I. Use of hormone replacement therapy. Lancet 1996; 348:1521.
31. Wollter-Svensson LO, Stadberg E, Andersson K, Mattsson LA, Odlind V, Persson I. Intrauterine administration of levonorgestrel in two low doses in HRT. A randomized clinical trial during one year: effects on lipid and lipoprotein metabolism. Maturitas 1995; 22:199-205.
32. Karlberg J, Mattsson LA, Wiklund I. A quality of life perspective on who benefits from estradiol replacement therapy. Acta Obstet Gynecol Scand 1995; 74:367-72.
33. Gredmark T, Kvint S, Havel G, Mattsson LA. Histopathological findings in women with postmenopausal bleeding. Br J Obstet Gynaecol 1995; 102:133-6.
34. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993; 168:824-30.
35. Wiklund I, Karlberg J, Lindgren R, Sandin K, Mattsson LA. A Swedish version of the Women's Health Questionnaire. A measure of postmenopausal complaints. Acta Obstet Gynecol Scand 1993; 72:648-55.
36. Nathorst-Boos J, Wiklund I, Mattsson LA, Sandin K, von Schoultz B. Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand 1993; 72:656-60.
37. Milsom I, Mattsson LA, Andersson K. [Uterine curettage. Is it necessary in the future?]. Lakartidningen 1993; 90:4425-8.
38. Mattsson LA, Samsioe G, von Schoultz B, Uvebrant M, Wiklund I. Transdermally administered oestradiol combined with oral medroxyprogesterone acetate: the effects on lipoprotein metabolism in postmenopausal women. Br J Obstet Gynaecol 1993; 100:450-3.
39. Wiklund I, Holst J, Karlberg J, Mattsson LA, Samsioe G, Sandin K, Uvebrant M, von Schoultz B. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas 1992; 14:211-24.
40. Sporrong T, Rybo G, Mattsson LA, Vilbergson G, Crona N. An objective and subjective assessment of uterine blood loss in postmenopausal women on hormone replacement therapy. Br J Obstet Gynaecol 1992; 99:399-401.
41. Carlsson SA, Hokegard KH, Mattsson LA. Megacystis-microcolon-intestinal hypoperistalsis syndrome. Antenatal appearance in two cases. Acta Obstet Gynecol Scand 1992; 71:645-8.
42. Andersson K, Mattsson LA, Rybo G, Stadberg E. Intrauterine release of levonorgestrel--a new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 1992; 79:963-7.
43. Samsioe G, Mattsson LA, Nilsson S. [Non-smoking women regardless of age, may use modern oral contraceptives]. Lakartidningen 1991; 88:619-20.
44. Nielsen TF, Hagberg H, Ljungblad U, Ladfors L, Mattsson LA. [Antibiotic prevention in acute Cesarean section reduces the frequency of infectious complications]. Lakartidningen 1991; 88:2393-5.
45. Bergbrant A, Mattsson LA, Kutti J. [Were the severe adverse effects on several organs and the marked blood pressure increase caused by oral contraceptives?]. Lakartidningen 1991; 88:621-2.
46. Sporrong T, Mattsson LA, Samsioe G, Stigendal L, Hellgren M. Haemostatic changes during continuous oestradiol-progestogen treatment of postmenopausal women. Br J Obstet Gynaecol 1990; 97:939-44.
47. Samsioe G, Mattsson LA. Some aspects of the relationship between oral contraceptives, lipid abnormalities, and cardiovascular disease. Am J Obstet Gynecol 1990; 163:354-8.
48. Uvebrant M, Bergstrom H, Hansson G, Mattsson LA. Endometrial sampling using the Mi Mark procedure as a primary routine: first year's experience. Maturitas 1989; 11:5-12.
49. Sporrong T, Hellgren M, Samsioe G, Mattsson LA. Metabolic effects of continuous estradiol-progestin therapy in postmenopausal women. Obstet Gynecol 1989; 73:754-8.
50. Sporrong T, Samsioe G, Larsen S, Mattsson LA. A novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy. Maturitas 1989; 11:209-15.
51. Mattsson LA, Ladfors L. [Active management of labor by means of the Dublin model]. Lakartidningen 1989; 86:2868-71.
52. Mattsson LA, Cullberg G, Eriksson O, Knutsson F. Vaginal administration of low-dose oestradiol--effects on the endometrium and vaginal cytology. Maturitas 1989; 11:217-22.
53. Sporrong T, Hellgren M, Samsioe G, Mattsson LA. Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints. Br J Obstet Gynaecol 1988; 95:1042-8.
54. Cullberg G, Mattsson LA. Ethinylestradiol and desogestrel, alone or in combination with two doses of estriol. Effects on plasma proteins. Acta Obstet Gynecol Scand 1988; 67:167-9.
55. Jarnfelt-Samsioe A, Eriksson B, Mattsson LA, Samsioe G. Serum lipids and lipoproteins in pregnancies associated with emesis gravidarum. Gynecol Endocrinol 1987; 1:51-60.
56. Mattsson LA, Cullberg G, Samsioe G. The relative fatty acid composition of serum lecithin and cholesterol ester: influence of an estrogen-progestogen regimen in climacteric women. Am J Obstet Gynecol 1986; 155:174-7.
57. Crona N, Enk L, Mattsson LA, Samsioe G, Silfverstolpe G. Progestogens and lipid metabolism. Maturitas 1986; 8:141-58.
58. Mattsson LA, Samsioe G. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen. Acta Obstet Gynecol Scand Suppl 1985; 130:53-8.
59. Mattsson LA, Silfverstolpe G, Samsioe G. Fatty acid composition of serum lecithin and cholesterol ester in the normal menstrual cycle. Horm Metab Res 1985; 17:414-7.
60. Cullberg G, Hamberger L, Mattsson LA, Mobacken H, Samsioe G. Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome. Acta Obstet Gynecol Scand 1985; 64:195-202.
61. Cullberg G, Hamberger L, Mattsson LA, Mobacken H, Samsioe G. Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination. Acta Obstet Gynecol Scand 1985; 64:203-7.
62. Mattsson LA, Cullberg G, Samsioe G. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism. Acta Obstet Gynecol Scand 1984; 63:673-7.
63. Mattsson LA, Silfverstolpe G, Samsioe G. Lipid composition of serum lipoproteins in relation to gonadal hormones during the normal menstrual cycle. Eur J Obstet Gynecol Reprod Biol 1984; 17:327-35.
64. Mattsson LA, Cullberg G, Hamberger L, Samsioe G, Silfverstolpe G. Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertil Steril 1984; 42:579-84.
65. Cullberg G, Knutsson F, Mattsson LA. A new combination of conjugated equine oestrogens and medroxyprogesterone for treatment of climacteric complaints. Maturitas 1984; 6:55-63.
66. Mattsson LA, Cullberg G, Lindstedt G. Ethinylestradiol administered by oral and sublingual routes: a comparative study in ovariectomized women. Horm Metab Res 1983; 15:36-40.
67. Mattsson LA, Cullberg G. Vaginal absorption of two estriol preparations. A comparative study in postmenopausal women. Acta Obstet Gynecol Scand 1983; 62:393-6.
68. Mattsson LA, Cullberg G. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women. Acta Obstet Gynecol Scand 1983; 62:397-401.
69. Mattsson LA, Abrahamsson L, Cullberg G, Samsioe G. Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins. Arch Gynecol 1983; 233:101-7.
70. Milsom I, Mattsson LA, Dahlen-Nilsson I. Antenatal diagnosis of osteogenesis imperfecta by real time ultrasound: two case reports. Br J Radiol 1982; 55:310-2.
71. Mattsson LA, Cullberg G, Samsioe G. Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints. Maturitas 1982; 4:95-102.
 
 

 cdultrasound@hotmail.com